Mark A. Glickman

Companies

• BioStem Technologies, Inc.Board member Aug 14, 2026 to now¹
• MetaVia Inc.Board member May 12, 2023 to now²
• TherapeuticsMD, Inc.Chief executive officer Dec 9, 2022 to Dec 9, 2022³
• TherapeuticsMD, Inc.Chief Business Officer Oct 15, 2021 to Mar 31, 2022⁴
• Esperion TherapeuticsChief Commercial Officer Dec 21, 2018 to Jan 3, 2020⁵
• Genome Therapeutics CorporationSVP, Sales & Marketing Jul 30, 2008 to Jul 30, 2008⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• MMetaVia Inc. MTVA20,629 shares⁷$28.3K at $1.37Jun 8, 2026
• BTBioStem Technologies, Inc. BSEM7,671 shares⁸$16.0K at $2.09Aug 27, 2026
• TTherapeuticsMD, Inc. TXMD1,294 shares⁹$2.5K at $1.93Dec 6, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 27, 2026Exercised options 7,671 shares of BioStem Technologies, Inc.⁸
• Jun 8, 2026Granted 17,186 shares of MetaVia Inc.⁷
• Jun 30, 2025Granted 28,147 shares of MetaVia Inc.¹⁰
• Jun 7, 2024Granted 5,051 shares of MetaVia Inc.¹¹
• Jul 27, 2023Granted 12,500 shares of MetaVia Inc.¹²
• Jul 27, 2023Granted 25,000 shares of MetaVia Inc.¹²
• Dec 6, 2022Sold 440 shares at $4.92 of TherapeuticsMD, Inc.⁹
• Dec 6, 2022Exercised options 1,734 shares of TherapeuticsMD, Inc.⁹